Évfolyam:
2021/22
Kutatási terület:
Nőgyógyászat & Urológia
Ország:
Magyarország
Intézmény:
Semmelweis Egyetem
PhD szakterület:
nőgyógyászat
Number of meta-analyses: 2
Project Description:
István Baradács is a resident gynecologist at the Department of Obstetrics and Gynecology of Semmelweis University. He is currently working on a meta-analysis examining the efficacy and safety of targeted therapy in gynecological malignancies. The clinical implication of this study may be the improved overall survival of patients with cancer. He also aims to participate in a clinical trial that aims to develop a unified testing and scoring system for the diagnosis of HER2-positive endometrial carcinoma.
Publications
- PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials - IF: 4.000, Quality: Q2, Journal: J Ovarian Res
- Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis - IF: 3.000, Quality: Q1, Journal: J Clin Med